ArticlePharmaceuticals (Basel, Switzerland)2022

Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma.

Hironao Okubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.